Providing Health Services and Sensitisation at Zambian Traditional Ceremonies

In the photo CIDRZ Senior Community Advisor Mr Fresher Maphiri and MC Community Coordinator Bright Jere meet with his Royal Highness Senior Chief Nacilele of Kaoma at his Royal Palace. Chief Nacilele is an advocate for medical male circumcision and encourages all men in his chiefdom to have the procedure. He says that all seven of his grand sons have been circumcised.

Zambia is blessed with over 70 distinct tribes and many have annual traditional ceremonies that bring throngs of tribesmen together to celebrate their cultural diversity. Events such as these provide an excellent opportunity to reach people with health services, accurate health messages, and dispel misconceptions.

With the support of the US PEPFAR and CDC partnership, CIDRZ community teams attend these events, and recently they traversed the country to provide HIV testing and counselling, and provide information and health messages about medical male circumcision, ART adherence and tuberculosis screening at the Nc’wala Traditional Ceremony of the Ngoni people of Eastern Province, followed by the Kuomboka Traditional Ceremony of the Lozi speaking people of Western Province.  Over 2000 people received HIV testing and counselling at these two events, and interested men were booked for medical circumcision at the nearest health facilities offering the service.

After the Kuomboka Traditional Ceremony, the CIDRZ team also were privileged to meet with six of the local Lozi traditional leaders, or their representatives, to seek the intervention of the Royal Highnesses to assist in increasing the uptake of health services, particularly of HIV testing, male circumcision (MC) and antiretroviral therapy (ART) adherence, amongst their people.

In addition to meeting with the KUTA, full cabinet of the Lozi Paramount Chief, the Litunga; they visited the Chiefs in Senanga, Kalabo, Mongu, Limulunga and Kaoma.

Construction of Nachitete Mini Hospital Gives Hope to Chongwe Community


Over the years, I have donated land for the construction of various government institutions including the Chongwe District Hospital and schools. All these have been done after seeing the need and demand for the critical services in my chiefdom,” expressed Her Royal Highness Senior Chieftainess Nkomeshya Mukamambo II.

The Nachiteti Mini Hospital

Our healthcare system must be effective, efficient, accessible, acceptable, equitable and safe to deliver quality service that improves patient outcomes.” Minister of Health, Hon. Dr. Chitalu Chilufya as he officially commissioned the health facility.

The facility was upgraded by the Zambian government. Speaking during the  event, Lusaka Provincial Minister, Hon. Japhen Mwakalombe said “the most vulnerable people who are in most cases – women and children – especially in rural areas, need well-designed healthcare and education systems closer to their households. This will not only make their lives better, but it will also encourage them to seek early medical care whenever they need it.

With support from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the CDC partnership, CIDRZ is proud to have been part of the official opening of the Nachitete Mini Hospital in Chongwe District where we were on-site to provide HIV testing and counselling, and screening for cervical cancer.

In addition, CIDRZ will continue to provide HIV testing and counselling, Voluntary Medical Male Circumcision, and support the Option B Plus programme for HIV-positive pregnant or breastfeeding women offering them life-long antiretroviral treatment (ART). At the event we reiterated our commitment to work with the health facility to provide quality health services to the Nachitete area, including parts of Lusaka and Chilanga Districts which previously used to access services from other distant facilities. CIDRZ will continue to support and and strengthen the health system to ensure that the clinic becomes one of the ART centres in the District.

CIDRZ Joins the HIV Coverage, Quality and Impact Network (CQUIN) Learning Network

Dr Sikazwe fourth from left on the panel “Implementing Differentiated Care: Innovations and Challenges”

Last week CIDRZ CEO Dr Izukanji Sikazwe attended the HIV Coverage, Quality and Impact (CQUIN) Learning Network meeting Partnering to Advance Differentiated Care in Umhlanga, South Africa  The event was supported by the Columbia University, Mailman School of Public Health ICAP program and the keynote address was delivered by the ICAP Global Director, Dr Wafaa El-Sadr. The participating countries of South Africa, Zambia, Kenya, Mozambique, Zimbabwe, Swaziland, and Malawi were represented by members of their Ministries of Health, national AIDS program and other key stakeholders. Dr Sikazwe sat on the panel “Implementing Differentiated Care: Innovations and Challenges” as well as presenting a Zambia country update about our CIDRZ experience. CIDRZ is currently conducting a differentiated care implementation study called Community ART for Retention in Zambia or “Community ART” with grant support from the Bill & Melinda Gates Foundation. Other Zambia representatives were: Dr Bridget Mugisa, CDC Branch Chief Care and Treatment, Dr Ignace Gashongore University of Maryland Chief of Party, Dr Daniel Makawa Deputy Director Clinical Care Ministry of Health, Theresa Sikateyo Country Director ICAP, and Angela Taylor, Acting Country Director Equip.

The purpose of CQUIN is to foster a learning network of countries interested in partnering to enhance and accelerate the implementation of high-quality differentiated service delivery for HIV. The ultimate goal is to increase the number of people living with HIV initiating and sustaining highly effective HIV treatment with sustained viral suppression.




Call for Abstracts: 36th Annual Pharmacy Scientific Conference: Shifting Paradigms Towards Pharmaceutical Research in Disease Prevention and Anti-Microbial Resistance

CALL FOR ABSTRACTS : 36th Annual Pharmacy Scientific Conference
SUBMISSION DEADLINE: 12 May 2017  23:59 Central Africa Time

36th Annual Pharmacy Scientific Conference
Theme: Shifting Paradigms Towards Pharmaceutical Research in Disease Prevention and Anti-Microbial Resistance
15-16 June 2017
Chrismar Hotel
Livingstone, Zambia

The Annual Pharmacy Scientific Conference enables dissemination of current, original pharmaceutical research and practice that introduces new ideas, concepts and understanding in the these four sub-themes:

  • Pharmaceutical Technology and Innovation 
  • Disease Prevention and Health Promotion
  • Rationale Use of Medicine
  • Pharmaceutical Practice and Policy

The Pharmaceutical Society of Zambia Journal Committee and the Conference Editorial Committee will review submitted abstracts and evaluate them based on the following criteria:

 – Direct relevance to the selected sub-theme
 – Scientific merit
 – Submission of a clearly written, well organized and structured abstract

Abstracts should be no more than 500 words and should concisely describe:

 – Background
 – Aims/Objectives
 – Methodology
 – Results/Findings
 – Conclusion(s)


Submission Deadline: 11:59 pm CAT   on  May 12, 2017
Please do not submit an abstract if you are not confident that you will be able to attend the conference and make the presentation.


– All abstracts should be in English.
– Incomplete or inaccurate abstracts will be rejected.
– Each attendee may present no more than two abstracts.
– Presenting an abstract is a voluntary effort and attendees will not be paid to present.
Abstract acceptances will apply only to the presenting author. Acceptances are not transferable to co-authors.


Only capitalize the first word, the word following a colon, and all proper nouns and adjectives as shown in the example below. Italicize Latin species names.

Example: Combating antimicrobial resistance (AMR) through improved rational drug use in Chongwe District”

  • The first word of the title should not be A,  An, or The.
  • Spell out acronyms and symbols such as equal, plus and minus.
  • Do NOT use brand names of medications or other products in the title
  • Abbreviations may be used in the title, provided the name in full is outlined in the body of the abstract.

A concise statement of no more than 500 words describing the:

Background, Aims/Objectives, Methodology, Results/Findings and Conclusion(s)

– Arial, 12pt font, single-spaced and left aligned.
– DO NOT use all caps.
 – Use standard abbreviations only.
– Spell out a proper name in full at the first mention, followed by the abbreviation in parenthesis.
– The abstract title, author names, affiliations and references are not included in the 500 word limit.
– Include no more than five key words in a separate line at of your abstract.

To Submit Your Abstract:

Email it to BOTH:     and 

In the subject line:
– Write the Title of your abstract

In the body of your email include in this order:
– Specific sub-theme
– Oral, or Poster presentation
– Abstract Title
– Presenting Author, institutional affiliation, contact details, including email
– Name and Organisation of Co-Authors in the order they should appear in the Abstract book
– Brief biography (no more than 50 words) of the Presenting Author

If after you have submitted your abstract you choose to withdraw your submission, email     and and type WITHDRAWN and the Title of your abstract in the subject line.


Abstract Evaluation Process and Criteria:

The Pharmaceutical Society of Zambia Journal Committee and the Conference Editorial Committee will review the abstracts based on the following criteria:

  • Direct relevance to the selected sub-theme
  • Scientific merit
  • Submission of a clearly written, well organized and structured abstract
  • Strict adherence to the submission guidelines outlined above

The Committee will notify authors with formal acceptance or rejection notices sent to the email address provided during the abstract submission process.

Note: If your abstract is accepted, the Committee will indicate if it will be an oral presentation or poster.

Dissemination of Abstracts:

Accepted abstracts will be published in the Pharmaceutical Journal of Zambia, June 2017 Edition [ISSN-2520-4327 (Print)] and disseminated to all conference attendees in print format.

PREEMI – Working with Communities to Increase Facility Deliveries

In the densely-populated compound of Chawama in Lusaka, CIDRZ recently presented findings of an assessment that explained reasons why up to 80% of women living in Zone One were choosing not to go to the local health centre to deliver. In attendance at the presentation were hospital staff, community members and representatives from the Lusaka District Health Office.

The Zone One assessment concluded that most pregnant women in this area of the Chawama compound are knowledgeable about the risks and complications of pregnancy and labour, but cultural and religious barriers to early health-seeking and facility deliveries are still strong. Family members, and especially spouses, play a major role in women making decisions about their healthcare, including delivering at a health facility. In addition, the type of service and support a woman receives from the facility provider either motivated or demotivated her to access the health facility in her time of need.

With generous funding from The ELMA Foundation, CIDRZ is conducting a programme called Preterm Resources, Education, and Effective Management of Infants, or PREEMI. The CIDRZ PREEMI team are working with local Safe Motherhood Action Groups (SMAGs) to help sensitise members of the community about important health issues as they relate to pregnant mothers, unborn babies and infants. Using drama performances, one-to-one and group meetings, trained SMAG members explain the importance of early healthcare seeking in pregnancy and labour, and challenge some of the cultural, religious, and healthcare service communication and provision barriers that prevent this.

35 Local Chawama Women Trained as SMAGs

Thus, women in the community with SMAG training can be excellent local resources to pregnant women and their families by providing information, encouraging facility deliveries, and demystifying community perceptions about the health facility. But clearly, good communication skills and care provided by health facility staff to pregnant and labouring women play a major role in the success of this initiative. Moving forward  more community education on the importance of facility delivery targeting spouses, family members, traditional elders and church leaders is required, as well as training and systems approaches to improving the quality of care provided at local health facilities.

During the event, 35 SMAG members based in Chawama were presented with certificates of achievement at the Chawama Mini Hospital.

With PEPFAR and CDC Support, CIDRZ working towards strengthening TB management in Zambia

Photos: Dr Natalie Vlahakis, CIDRZ Clinical Care Specialist;
Outpatients registering for TB screening in Kanyama, Lusaka

CIDRZ, with the support of the United States President’s Emergency Plan for AIDs Relief (PEPFAR) and the Centers for Disease Control and Prevention (CDC) partnership, has been implementing the ‘Scaling-Up TB prevention, screening, diagnosis and care programme by rolling out the WHO 3″I’s strategy in 154 sites in Western, Eastern, Lusaka and Southern Provinces. This strategy entails Intensified TB Case Finding (ICF), provision of Isoniazid Preventative Therapy and TB Infection Control in HIV settings.

To achieve all this, with PEPFAR funding, CIDRZ has this year alone, procured two GeneXpert machines, facilitated installation of five other machines and is maintaining 15 GeneXpert machines in 4 provinces. We are also supporting 3 digital chest x-ray machines in Lusaka. Additionally, CIDRZ is engaged in TB/HIV service provision and linkages: over 352 healthcare workers and 182 Peer Educators have been trained in TB/HIV service provision,” says Dr Natalie Vlahakis, CIDRZ Clinical Care Specialist during the commemoration of this year’s World TB Day commemorated under the Global Theme: Unite to End TB.

CIDRZ programmes are Inclusive 

Since 2010, the CIDRZ TB department has worked closely with Zambia Correctional Services to support entry and exit screening for TB and HIV in prison inmates and remandees, implement the 3’I’s and to provide TB and HIV prevention, care and treatment services in prisons,” Dr Vlahakis added.

CIDRZ also works with the National TB programme in the revision of TB guidelines, manuals and recording tools to strengthen the healthcare interventions against the disease.

Gracing the WTB Day event, Chongwe Mayor, His Lordship Geoffrey Chumbwe said “TB remains a major public health problem hence the World TB Day Commemoration provides a big opportunity to make all Zambians aware about the causes and precautions of TB.”

As a lead up to this WTB Day, CIDRZ provided screening services for inmates at the Lusaka Correctional Facility, as well outpatients at the Kanyama First Level Hospital in Lusaka.

2013-2014 estimates indicate that for every 100,000 Zambians, 455 have TB. The vast majority of TB is curable if found and treated.

New Closing Date – Deputy Chief Executive Officer Vacancy – 31 March 2017

Deputy Chief Executive Officer (DCEO)                      Ref No. DC/EX/17/01/17

Reports to Chief Executive Officer (CEO). The incumbent develops a strong understanding of the Government of the Republic of Zambia (GRZ) national strategic plans for health, new developments that could affect CIDRZ, and global developments relating to the Sustainable Development Goals and trends in donor investments. S/he works closely with the CEO in the engagement and building of strategic relationships with the GRZ donor agencies, CIDRZ donor agencies, non-governmental partners, civil society groups including faith-based organisations, and the media.

Main Duties:
Provides high-level directional and strategic input into CIDRZ business development activities, including around partnerships and development of consortia. Drives the CIDRZ strategic planning process, including measurement of progress against strategic objectives and departmental accountability for results, and ensures that CIDRZ is meeting its mission. Understands the risks facing the organisation, and works closely with Executive Committee (EXCO) members, the Board of Directors and outside parties to put into place effective risk mitigation strategies. Works in collaboration with EXCO members to ensure the effectiveness and compliance of operational, programmatic and research arms of the organisation. Directly oversees the Business Development and Grants and Contracts units and provides support to the CEO in the management of direct reports, as assigned. Sets an annual communications plan with the Communications unit and ensures timely completion of high quality external communications and regular internal communication. Sets effective agendas for and co-chairs monthly meetings of the Leadership Team, and bi-weekly meetings of the EXCO. Provides internal “management consultations” for troubled units or managers. Serves as a signatory for financial agreements between CIDRZ, donor organisations, and subcontractors. Participates in the development and implementation of innovative clinical, epidemiological, and operational research studies, designed to address key issues identified by the Zambian Ministry of Health (MOH). Supports the development and implementation of policies that ensure CIDRZ representation at the policy level, including in key Technical Working Groups supported by the MOH and other Ministries. Supports the CEO and broader organisation in meeting programmatic, research, training and policy mission, as required.


– Minimum of 8 years’ Management Consulting/Senior Executive management experience
– Postgraduate degree; preferably MBA, MPH and/or PhD, MD
– Proven results-oriented leader, with high-level skills in organisational management, able to manage and create clarity in a complex environment
– Experience managing effectively in a multi-cultural setting
– Excellent written and verbal English communication skills are a prerequisite
– Experience in healthcare delivery, management and research is preferred
– Experience managing program and research grants is preferred 

NEW Closing Date for receiving applications is 31st March, 2017.

Suitably qualified candidates are invited to apply; however only shortlisted candidates will be contacted. Please send application letter quoting Reference Number above, relevant academic and professional certificates, and detailed CV with day-time telephone number(s) to:

CIDRZ Human Resources Director
PO Box 34681, LUSAKA or email:

Mr Ackim Sinkala Joins CIDRZ as CFO

CIDRZ is pleased to welcome Mr Ackim Sinkala who joins the organisation as Chief Financial Officer. Mr Sinkala has over 21 years’ experience in the finance and accountancy fields in Zambia. His most recent appointment was Financial Controller at Investrust Bank. Prior to that he served as Chief Financial Officer at Intermarket Banking Corp. (Z) Ltd., Finance Manager at Zambia Centre for Accountancy Studies (ZCAS), Financial Systems Manager at Zambia Sugar Plc, Management Accountant at Spectra Oil Corporation, and Administrative Accountant at Zambia Consolidated Copper Mines.

He is an Associate Member of the Chartered Institute of Management Accountants (ACMA) and a Fellow of the Zambia Institute of Chartered Accountants (FZICA). Mr Sinkala holds a Masters of Business Administration from Heriot Watt University, Edinburgh Business School, UK, and Chartered Institute of Management Accountants (CIMA-UK), Association of Accounting Technicians (AAT), and College Certificate in Accountancy qualifications.

[CLOSED] Global Public Health Fellowship Opportunity 2017/18 APPLICATION NOW OPEN!

Are you interested in global public health?

Do you have a Master’s degree?

Are you interested in working with CIDRZ?

Established in 2001, CIDRZ is the largest independent non-governmental healthcare and research organisation in Zambia. We conduct locally-relevant, leading-edge healthcare research, strengthen primary health care systems in multiple focus areas, and run a state-of-the-art medical and research diagnostic laboratory. Through close collaboration with the Government of the Republic of Zambia Ministry of Health and other Ministries, and key local and international stakeholders we fulfil our mission to:

“Improve access to quality healthcare in Zambia through capacity development, exceptional implementation science and research, and impactful and sustainable public health programmes”

  • Tuberculosis
  • Hepatitis
  • Women’s Health
  • Newborn Health
  • Child Health
  • Diarrhoeal Disease
  • Water and Sanitation
  • Lab Science

HealthCorps Fellowship Length: 10 – 12 months; starting early August 2017
Available Financial Support: Modest monthly bursary to cover basic living expenses,local medical services membership, & emergency evacuation insurance


Go to:

Closing Date for Applications: 20 March 2017

CIDRZ HIV Preventive Vaccine Trial – HVTN 111 Opens

HVTN 111: A Phase 1, HIV Preventive Vaccine Trial Opens at Matero Ref 

AIDS, the disease caused by the human immunodeficiency virus (HIV) is a huge problem around the world, and especially in countries in sub-Saharan Africa such as Zambia. While we have an excellent ART treatment programme to help those infected with HIV/AIDS to live well, finding a safe and effective HIV vaccine that protects against getting the virus is key to ending the epidemic!

The HIV Vaccine Trials Network 111 is a  Phase 1 clinical trial which is a carefully controlled and monitored research study which aims to find out if the specific study vaccine being used is safe and how the body’s defence mechanisms respond to it.

CIDRZ is the Zambian site conducting the HVTN 111 study. It is also being conducted at sites in South Africa and Tanzania. Funding for the study is provided by the HVTN, the US Division of AIDS (DAIDS), the Bill & Melinda Gates Foundation, GlaxoSmithKline (formerly Novartis) and the IPPOX Foundation.

About the HIV Vaccine Trials Network (
The mission of the HVTN is to fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV infections globally. The HVTN, with expert scientists from medical institutions across the globe alongside top clinicians, educators, and dedicated community representatives, is committed to conducting scientifically rigorous and ethical trials.

All clinical studies done by the HVTN test the safety of vaccine candidates. They also look to see if people can get these vaccines without having side effects that make them very uncomfortable. They look at the immune responses that are generated in people who receive these vaccines. Some of their studies look at whether these vaccines protect against HIV infection, or control HIV if infection does occur (efficacy studies).

To date, the HVTN has conducted the majority of the published, presented, or ongoing clinical trials of preventive HIV vaccines worldwide. In the process, they have gained tremendous experience in administering an innovative global scientific organization, which combines the intellectual robustness and creativity of academia with the focus and infrastructure of industry.

CIDRZ is proud to partner with the HVTN in this important HIV research.